Towards 3-fold sustainability in biopharmaceutical process development and product distribution

Author:

Sarkis Miriam12,Sachio Steven12,Shah Nilay12,Kontoravdi Cleo12,Papathanasiou Maria M.12

Affiliation:

1. Sargent Centre for Process Systems Engineering, Imperial College London, SW7 2AZ, UK

2. Department of Chemical Engineering, Imperial College London, South Kensington Campus, London SW7 2AZ

Abstract

The (bio-)pharmaceutical industry is facing crossroads in an effort to ramp up its global capacity, while working to meet net-zero targets and to ensure continuous drug supply. Beyond geopolitical challenges faced worldwide, (bio-)pharmaceutical processes have been historically very complex to design, optimise and integrate in a global distribution network that is resilient and adaptable to changes. In this paper we offer a perspective of how Process Systems Engineering (PSE) tools can support and advance (bio-)pharma practices with an outlook towards 3-fold sustainability. The latter is considering three main pillars, namely social (drug supply), economical and environmental sustainability. We discuss PSE contributions that have revolutionised process design in this space, as well as the optimisation of distributions networks in pharmaceuticals. We do this by means of example cases: one on model-based unit operation design and a second one on sustainable supply chain networks in the space of advanced therapeutics. As such, this contribution offers a perspective on how PSE methodologies can offer a systematic way to integrate social, environmental, and economical sustainability throughout process design and product distribution.

Publisher

PSE Press

Reference44 articles.

1. Office for Life Sciences (2021) Life Science Competitiveness Indicators 2020.

2. The Paris Agreement | UNFCCC. https://unfccc.int/process-and-meetings/the-paris-agreement. Accessed 15 Dec 2023

3. Dukart H, Lanoue L, Rezende M, Rutten P Six new pharmaceutical industry trends | McKinsey. https://www.mckinsey.com/capabilities/operations/our-insights/emerging-from-disruption-the-future-of-pharma-operations-strategy#. Accessed 15 Dec 2023

4. ACS GCI Pharmaceutical Roundtable Portal � ACS GCI Pharmaceutical Roundtable Portal. https://www.acsgcipr.org/. Accessed 15 Dec 2023

5. Sustainability - MSD. https://www.msd.com/company-overview/sustainability/. Accessed 15 Dec 2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3